Stay updated on Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page
- ChecktodayChange DetectedThe page revision has been updated to v3.5.3, reflecting a minor maintenance update to the page metadata. No study information or user-facing content is changed.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.5.2 added and Revision: v3.5.0 removed on the page footer as a versioning update.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedAdded Gastrointestinal stromal tumor as a topic and a Resources section linking to Genetic and Rare Diseases Information Center. These additions provide background context without changing core trial details.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check50 days agoChange DetectedA new revision label 'Revision: v3.4.3' was added. The previous label 'Revision: v3.4.2' was removed.SummaryDifference0.1%

- Check79 days agoChange DetectedChanges are limited to site revision updates (Revision: v3.4.2) and removal of a prior funding/operating-status notice; there are no changes to study details, eligibility, or contact information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anlotinib in Advanced Gastrointestinal Stromal Tumor Clinical Trial page.